159 related articles for article (PubMed ID: 20429761)
1. Pneumothorax induced by radiofrequency ablation for hepatocellular carcinoma beneath the diaphragm under real-time computed tomography-fluoroscopic guidance.
Miura H; Yamagami T; Terayama K; Yoshimatsu R; Matsumoto T; Nishimura T
Acta Radiol; 2010 Jul; 51(6):613-8. PubMed ID: 20429761
[TBL] [Abstract][Full Text] [Related]
2. Transpulmonary radiofrequency ablation for hepatocellular carcinoma under real-time computed tomography-fluoroscopic guidance.
Kato T; Yamagami T; Hirota T; Matsumoto T; Yoshimatsu R; Nishimura T
Hepatogastroenterology; 2008; 55(85):1450-3. PubMed ID: 18795709
[TBL] [Abstract][Full Text] [Related]
3. Feasibility, safety, and efficacy of artificial carbon dioxide pneumothorax for computed tomography fluoroscopy-guided percutaneous radiofrequency ablation of hepatocellular carcinoma.
Shibamoto K; Mimura H; Fukuhara Y; Nishino K; Kawamoto H; Kato K
Jpn J Radiol; 2021 Nov; 39(11):1119-1126. PubMed ID: 34089475
[TBL] [Abstract][Full Text] [Related]
4. Transpulmonary computed tomography-guided radiofrequency ablation of liver neoplasms abutting the diaphragm with multiple bipolar electrodes.
Zhang Q; Li X; Pan J; Wang Z
Indian J Cancer; 2015 Dec; 52 Suppl 2():e64-8. PubMed ID: 26728677
[TBL] [Abstract][Full Text] [Related]
5. Effect of CT fluoroscopy-guided transpulmonary radiofrequency ablation of liver tumours on the lung.
Iguchi T; Inoue D; Yabushita K; Sakaguchi K; Tatsukawa M; Sasaki H; Kanazawa S
Br J Radiol; 2012 Aug; 85(1016):e373-7. PubMed ID: 22374277
[TBL] [Abstract][Full Text] [Related]
6. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Nishimura T
J Vasc Interv Radiol; 2006 Oct; 17(10):1625-9. PubMed ID: 17057004
[TBL] [Abstract][Full Text] [Related]
7. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
[TBL] [Abstract][Full Text] [Related]
8. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience.
Takaki H; Yamakado K; Nakatsuka A; Yamada T; Shiraki K; Takei Y; Takeda K
AJR Am J Roentgenol; 2013 Mar; 200(3):658-64. PubMed ID: 23436859
[TBL] [Abstract][Full Text] [Related]
9. Computed Tomography-guided Radiofrequency Ablation for Sub-diaphragm Hepatocellular Carcinoma: Safety and Efficacy of Inducing an Artificial Pneumothorax.
Fujiwara H; Arai Y; Ishii H; Kanazawa S
Acta Med Okayama; 2016 Jun; 70(3):189-95. PubMed ID: 27339208
[TBL] [Abstract][Full Text] [Related]
10. Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms.
Nour-Eldin NE; Naguib NN; Saeed AS; Ackermann H; Lehnert T; Korkusuz H; Vogl TJ
AJR Am J Roentgenol; 2009 Jul; 193(1):W43-8. PubMed ID: 19542382
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
12. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.
Shibata T; Shibata T; Maetani Y; Kubo T; Itoh K; Togashi K; Hiraoka M
J Vasc Interv Radiol; 2004 Nov; 15(11):1323-7. PubMed ID: 15525754
[TBL] [Abstract][Full Text] [Related]
13. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle].
Marone G; Francica G; D'Angelo V; Iodice G; Pastore P; Altamura G; Cusati B; Siani A
Radiol Med; 1998 Jun; 95(6):624-9. PubMed ID: 9717546
[TBL] [Abstract][Full Text] [Related]
14. Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation.
Yamakado K; Nakatsuka A; Takaki H; Sakurai H; Isaji S; Yamamoto N; Shiraki K; Takeda K
AJR Am J Roentgenol; 2010 Feb; 194(2):530-5. PubMed ID: 20093620
[TBL] [Abstract][Full Text] [Related]
15. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors.
Hiraki T; Tajiri N; Mimura H; Yasui K; Gobara H; Mukai T; Hase S; Fujiwara H; Iguchi T; Sano Y; Shimizu N; Kanazawa S
Radiology; 2006 Oct; 241(1):275-83. PubMed ID: 16908680
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
Rhim H; Lim HK; Kim YS; Choi D
AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic US-guided radiofrequency ablation of unresectable hepatocellular carcinoma in liver cirrhosis: feasibility and clinical outcome.
Casaccia M; Andorno E; Nardi I; Troilo B; Barabino G; Santori G; Valente U
J Laparoendosc Adv Surg Tech A; 2008 Dec; 18(6):797-801. PubMed ID: 18922065
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome.
Toyoda M; Kakizaki S; Horiuchi K; Katakai K; Sohara N; Sato K; Takagi H; Mori M; Nakajima T
World J Gastroenterol; 2006 Jan; 12(4):608-11. PubMed ID: 16489676
[TBL] [Abstract][Full Text] [Related]
19. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.
Llovet JM; Vilana R; Brú C; Bianchi L; Salmeron JM; Boix L; Ganau S; Sala M; Pagès M; Ayuso C; Solé M; Rodés J; Bruix J;
Hepatology; 2001 May; 33(5):1124-9. PubMed ID: 11343240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
